CASAROTTO, DINO
 Distribuzione geografica
Continente #
NA - Nord America 3.592
EU - Europa 418
AS - Asia 251
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
SA - Sud America 1
Totale 4.266
Nazione #
US - Stati Uniti d'America 3.590
CN - Cina 238
SE - Svezia 122
FI - Finlandia 78
DE - Germania 61
UA - Ucraina 61
IT - Italia 42
GB - Regno Unito 34
FR - Francia 11
IN - India 8
IE - Irlanda 6
VN - Vietnam 5
EU - Europa 3
NL - Olanda 3
CA - Canada 2
AU - Australia 1
BR - Brasile 1
Totale 4.266
Città #
Fairfield 556
Chandler 461
Woodbridge 346
Jacksonville 300
Ashburn 246
Houston 244
Wilmington 224
Seattle 217
Ann Arbor 210
Cambridge 177
Princeton 110
Beijing 82
Roxbury 46
San Diego 45
Nanjing 44
Guangzhou 31
Boardman 26
Medford 24
Helsinki 21
Des Moines 19
London 16
Shenyang 15
Nanchang 13
Hebei 12
Redwood City 12
Jiaxing 10
Washington 10
Padova 9
Norwalk 8
Dublin 6
Jinan 6
Ogden 6
Changsha 5
Dong Ket 5
Munich 4
Shanghai 4
Tianjin 4
Indiana 3
Kharkiv 3
Kilburn 3
Auburn Hills 2
Borås 2
Casalnuovo di Napoli 2
Florence 2
Haikou 2
Ningbo 2
Bad Oeynhausen 1
Bari 1
Chicago 1
Hounslow 1
Ipatinga 1
Kwinana 1
Lancaster 1
Palermo 1
Phoenix 1
Redmond 1
San Francisco 1
San Severino Marche 1
Siena 1
Taizhou 1
Toronto 1
Verona 1
Vigonza 1
Totale 3.612
Nome #
High rejection score in the first year and risk of skin cancer in heart transplantation 128
Hancock II bioprosthesis: a glance at the microscope in mid-long-term explants 116
Surgical treatment of complete A-V canal defects in children before 3 months of age 107
Endothelin-1 and Its mRNA in the wall layers of human arteries ex vivo 101
Sulfinpyrazone reduces cyclosporine levels: a new drug interaction in heart transplant recipients 101
THE 24-HOUR RHYTHM OF BLOOD PRESSURE DIFFERS FROM THAT OF LEG HEMODYNAMICS IN ORTHOTOPIC HEART TRANSPLANT RECIPIENTS 100
Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur) 98
Unusual left ventricular mass. 98
DONOR SHORTAGE IN HEART-TRANSPLANTATION 97
Fibrous tissue overgrowth on Hancock mitral xenografts: a cause of late prosthetic stenosis. 95
Hancock II porcine bioprosthesis: excellent durability at intermediate-term follow-up 94
Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft 93
De novo noncutaneous malignancies in heart transplantation: a single-centre 15-year experience and risk factor analysis 92
Unexpected mechanical bileaflet valve thrombosis in mitral position: what is better to do, re-replacement or thrombolysis 90
Discordance between pre and post cardiac transplantat diagnosis: implications for pre and post operative decision making. 87
Reoperations for acute prosthetic thrombosis and pannus: an assessment of rates, relationship and risk. 87
Primary cardiac valve tumours 87
Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection 86
Isolation of intact aortic valve scaffolds for heart-valve bioprostheses: Extracellular matrix structure, prevention from calcification, and cell repopulation features 84
Prosthetic replacement of the tricuspid valve: biological or mechanical? 81
Surgical removal of a left atrial myxoma during pregnancy. 81
Thermal analysis characterization of aortic tissues for cardiac valve bioprostheses 80
Arterial switch operation after left ventricular retraining in the adult. 78
Multivariate analysis of survival after malfunctioning biological and mechanical prosthesis replacement. 78
Surgical treatment of complex cardiac anomalies: the 'one and one half ventricle repair 76
Skin cancer in heart transplant recipients - Risk factor analysis and relevance of immunosuppressive therapy 74
Skin cancer in heart transplant recipients: Risk factor analysis and relevance of immunosuppressive therapy 72
Surgical closure of apical ventricular septal defects through a right ventricular apical infundibulotomy 71
Mitral and aortic valve replacement in valvular rheumatoid heart disease. 71
Left ventricular rupture following mitral valve replacement with a Hancock bioprosthesis. 70
Monoclonal gammopathy in heart transplantation: clinical significance and risk factors 69
Histological survey of the saphenous vein before its use as autologous aortocoronary bypass graft. 68
Discordance between pre and post cardiaca transplant diagnosis: implications for pre- and post-operative decision making. 65
Pulmonary atresia, intact ventricular septum, and Ebstein anomaly of the tricuspid valve. Anatomic and surgical considerations. 64
High rejection score in the first year and risk of skin cancer in heart transplantation 63
Increased Myocardial GRP94 Amounts During Sustained Atrial Fibrillation: A Protective Response? 62
Mid-term follow-up in patients with Biocor porcine bioprostheses. 62
Case report: fibroelastoma of the papillary muscle of the mitral valve: diagnostic implications and review of the literature 61
Pressure-dependence of the Aortic Valve Gradient 61
Erratum: Surgical treatment of complex cardiac anomalies: The 'one and one half ventricle repair' (European Journal Cardiothoracis Surgery 22 (2002) 22 (431-437) PII: S1010794002003688) 60
Skin cancer in heart transplant recipients - Risk factor analysis and relevance of immunosuppressive therapy 58
Repair of congenital mitral valve dysplasia in infants and children: is it always possible? 56
Left main trunk ostial stenosis and aortic incompetence in Takayasu's arteritis 56
New trends in heart transplantation 55
Le indicazioni all'impiego di homograft e autograft nelle valvulopatie aortiche. 54
Cell composition of the human pulmonary valve: A comparative study with the aortic valve - The VESALIO* project 52
Wear tested pulmonary porcine valve: mechanical properties and ultrastructural findings. 45
Surgical treatment of comlete A-V canal defects in children before 3 months of age 45
Long-term results (from 5 to 7 years) with the Hancock S-G-P bioprosthesis. 45
Influence of marginal donors on early results after heart transplantation. 45
Donor age greater than 50 years does not influence midterm results of heart transplantation. 45
Tumori cardiaci: classificazione ed epidemiologia 43
Double criss-cross sternal wiring and chest wound infections [3] (multiple letters) 43
[Late aortic dissection after aortic valve substitution. Considerations on 5 operative cases]. 41
Terapie chirurgiche e malattie delle valvole cardiache 36
Cyclosporine-based steroid-freee therapy in pediatric heart transplantation: long term results. 36
Aortic valve replacement with pulmonary homografts. Early experience. 36
Transaortic gradient is pressure-dependent in a pulsatile model of the circulation 32
Malattie del cuore e del pericardio. 30
Mechanics of cryopreserved aortic and pulmonary homografts 30
Rupture of the posterior wall of the left heart at the atrio-ventricular groove following mitral valve replacement. 29
Influence of rejection on late graft function after heart transplantation. 27
High rejection score in the first year as a predictor of heart transplant recipients at risk of skin cancer 24
Searching for a correct method of evaluation of valve prosthesis performance. Laboratory assessment. 14
Impact of organ preservation techniques on outcome of cardiac transplantation in the era of donor pool expansion 10
Successful treatment of disseminated infection with Listeria monocytogenes in a heart transplant recipient [3] 1
Totale 4.296
Categoria #
all - tutte 14.662
article - articoli 14.037
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 625
Totale 29.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019366 0 0 0 0 0 0 0 0 0 85 159 122
2019/2020982 153 34 14 52 105 82 77 118 93 125 79 50
2020/2021611 20 56 22 64 33 62 21 68 105 53 77 30
2021/2022802 26 95 62 58 18 104 27 91 42 19 92 168
2022/2023716 148 101 20 114 111 97 0 37 54 1 27 6
2023/2024218 14 39 40 24 15 44 10 7 12 13 0 0
Totale 4.296